Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
Citations Over TimeTop 10% of 2011 papers
Abstract
The immune system can both promote and suppress cancer. Chronic inflammation and proinflammatory cytokines such as interleukin (IL)-1 and IL-6 are considered to be tumour promoting. In contrast, the exact nature of protective antitumour immunity remains obscure. Here, we quantify locally secreted cytokines during primary immune responses against myeloma and B-cell lymphoma in mice. Strikingly, successful cancer immunosurveillance mediated by tumour-specific CD4(+) T cells is consistently associated with elevated local levels of both proinflammatory (IL-1α, IL-1β and IL-6) and T helper 1 (Th1)-associated cytokines (interferon-γ (IFN-γ), IL-2 and IL-12). Cancer eradication is achieved by a collaboration between tumour-specific Th1 cells and tumour-infiltrating, antigen-presenting macrophages. Th1 cells induce secretion of IL-1β and IL-6 by macrophages. Th1-derived IFN-γ is shown to render macrophages directly cytotoxic to cancer cells, and to induce macrophages to secrete the angiostatic chemokines CXCL9/MIG and CXCL10/IP-10. Thus, inflammation, when driven by tumour-specific Th1 cells, may prevent rather than promote cancer.
Related Papers
- → Failure of immunosurveillance accelerates aging(2019)17 cited
- → The Effects of Clonal Heterogeneity on Cancer Immunosurveillance(2023)13 cited
- → Changes in the Profiles of Chemokines Secreted by Endothelial Cells and Monocytes under Different Coculturing Conditions(2011)5 cited
- → 27: Detection of HHV-6 in over a thousand samples: new types of infection revealed by the analysis of positive results(2006)1 cited
- Ecklonia cava Extract Exerts Anti-Inflammatory Effect in Human Gingival Fibroblasts by Suppression of Proinflammatory Cytokines and Chemokines(2019)